CLINICAL_TRIALS
trial_result
· 2017-12-06
Clinical Trial Update: A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053) [Phase 3]
Summary
Phase 3 trial assessing safety and efficacy of odanacatib (MK-0822) in men with osteoporosis has completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2017-12-06